Helping Toddlers and Parents Together
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04864808 |
Recruitment Status :
Recruiting
First Posted : April 29, 2021
Last Update Posted : April 29, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
ADHD Parenting | Behavioral: Behavioral Parent Training | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 10 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Treating ADHD Parents and Their Infants Via Telehealth: Developing an Early Parenting Intervention Using a Deployment-focused Intervention Design |
Actual Study Start Date : | April 22, 2021 |
Estimated Primary Completion Date : | May 2022 |
Estimated Study Completion Date : | July 2022 |
Arm | Intervention/treatment |
---|---|
Experimental: Behavioral Parenting Training |
Behavioral: Behavioral Parent Training
Parents will receive sessions of behavioral parent training with components specifically targeted toward parents with ADHD. The number of sessions will be informed based on stakeholder feedback. Treatment will be delivered via telehealth. |
- Acceptability [ Time Frame: up to 12 weeks ]Client Satisfaction Questionnaire (CSQ-8)- higher scores indicate more satisfaction

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 12 Months to 55 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- To be included in the stakeholder group, participants must work at a CNMC primary center or must be a parent with a toddler.
For inclusion to participate in the pilot intervention, a full-time guardian must, at the time of screening:
- Sign informed consent online
- Be between 21-55 years old (inclusive) and be English or Spanish-speaking
- Meet full DSM-5 criteria for ADHD, any subtype as determined by the SCID-5
- Have current CGI-S-ADHD rating ≥ 4 and < 7
- Commit to the entire study
- Be able to complete all study assessments virtually (i.e., they must have a device that connects to the internet with a camera)
Parents with common comorbid conditions will be included provided that: (a) they do not report active suicidal ideation with intent; and (b) if receiving an antidepressant medication, their medication is well-tolerated and has not changed within 30 days.
For inclusion to participate in the pilot intervention, toddlers must:
- be between ages of 12 - 35 months at time of consent
- score above the 75th percentile on the BITSEA problem scale
Exclusion Criteria:
- Parents will be excluded on the basis of current bipolar disorder, schizophrenia, psychoses, or other primary psychiatric disorder requiring other immediate treatment.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04864808
Contact: Andrea M Chronis-Tuscano, PhD | 301-405-9640 | achronis@umd.edu | |
Contact: Nicole E Lorenzo, PhD | 305-812-2399 | nlorenzo@umd.edu |
United States, District of Columbia | |
Children's National Medical Center | Recruiting |
Washington, District of Columbia, United States, 20010 | |
Contact: Nicole E Lorenzo, PhD nlorenzo@childrensnational.org | |
Principal Investigator: Andrea M. Chronis, PhD |
Principal Investigator: | Andrea M Chronis-Tuscano, PhD | University of Maryland, College Park |
Responsible Party: | Andrea Chronis-Tuscano, Professor, University of Maryland, College Park |
ClinicalTrials.gov Identifier: | NCT04864808 |
Other Study ID Numbers: |
R01MH118320-02S1 ( U.S. NIH Grant/Contract ) R01MH118320-02S1 ( U.S. NIH Grant/Contract ) |
First Posted: | April 29, 2021 Key Record Dates |
Last Update Posted: | April 29, 2021 |
Last Verified: | April 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |